News & Trends - MedTech & Diagnostics
When hearts and kidneys align: A united voice reshaping patient care

Tanya Hall, CEO of hearts4heart, and Chris Forbes, CEO of Kidney Health Australia, come together during Heart Failure Awareness Week (23–29 June) to shed light on the clinical relationship that is often overlooked: the inextricable link between heart failure and chronic kidney disease (CKD).
The two CEOs unravel the uncomfortable questions that often get buried beneath policy talk and clinical jargon. What does it actually mean to live with both heart and kidney disease in a health system that is still divided by disciplines, funding lines and postcode lotteries?
Grounded in lived experience, sharpened by policy knowledge, and coloured by their interactions with patients and clinicians, this podcast is a pulse-check on Australia’s readiness to move beyond awareness and into action.
From the rollout of the long-awaited NT-proBNP blood test in primary care, to the equity imbalance between public and private systems, to Australia’s standing on the global stage of heart-kidney health management, the conversation delves into the messy truths beneath the medical headlines. The duo share international insights, systemic frustrations, and above all, a shared vision: to break down the silos that continue to put patients last.
With a federal government re-elected in a landslide, both leaders are clear-eyed about what is needed next: meaningful health reforms, cross-sector collaboration, and a national conversation that includes those living with the dual burden of heart and kidney disease.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals

Target acquired: Merck and Omico set sights on fast-tracking precision cancer trials
Josie Downey, Managing Director of Merck Healthcare ANZ, and Professor David Thomas, Chief Science and Strategy Officer at Omico, unpack […]
MoreNews & Trends - Pharmaceuticals

Diagnosing the system, not just the patient: A rare alliance calls for reform
On Rare Cancers Awareness Day (26 June), Christine Cockburn, CEO of Rare Cancers Australia (RCA), and Paul Fenton, CEO of […]
MoreNews & Trends - Biotechnology

QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreNews & Trends - MedTech & Diagnostics

Pressure pays off – for now: Health insurers to boost private hospital payouts
Private hospitals have welcomed a shift by health insurers to return more of the premium revenue to patients and providers, […]
More